10 employees
Protectimmun iis focused on research and development of drugs especially in the field of allergic and chronic inflammatory diseases.
2007
Protectimmun GmbH raised undisclosed on May 4, 2011
Investors: EnjoyVenture Management GmbH, KfW and High-Tech Gründerfonds